ANDA 89603, held by Ani Pharms. Thioridazine Hydrochloride.
As of Nov 16, 2026, ANDA 89603 (Thioridazine Hydrochloride), held by Ani Pharms, was first approved by FDA on Nov 9, 1987, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 9, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Thioridazine Hydrochloride100MG/ML ยท concentrate;oral | Thioridazine Hydrochloride | Discontinued |
| Jun 17, 1999 | Supplement 5Manufacturing | Approved | None posted |
| Mar 23, 1999 | Supplement 4Manufacturing | Approved | None posted |
| May 31, 1996 | Supplement 3Manufacturing | Approved | None posted |
| Apr 2, 1992 | Supplement 2Labeling | Approved | None posted |
| Nov 9, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters